265 related articles for article (PubMed ID: 22836755)
21. Novel role of plasmacytoid dendritic cells in humans: induction of interleukin-10-producing Treg cells by plasmacytoid dendritic cells in patients with rheumatoid arthritis responding to therapy.
Kavousanaki M; Makrigiannakis A; Boumpas D; Verginis P
Arthritis Rheum; 2010 Jan; 62(1):53-63. PubMed ID: 20039433
[TBL] [Abstract][Full Text] [Related]
22. Murine thymic plasmacytoid dendritic cells.
Okada T; Lian ZX; Naiki M; Ansari AA; Ikehara S; Gershwin ME
Eur J Immunol; 2003 Apr; 33(4):1012-9. PubMed ID: 12672067
[TBL] [Abstract][Full Text] [Related]
23. Plasmacytoid dendritic cells represent a major dendritic cell subset in sentinel lymph nodes of melanoma patients and accumulate in metastatic nodes.
Gerlini G; Urso C; Mariotti G; Di Gennaro P; Palli D; Brandani P; Salvadori A; Pimpinelli N; Reali UM; Borgognoni L
Clin Immunol; 2007 Nov; 125(2):184-93. PubMed ID: 17827069
[TBL] [Abstract][Full Text] [Related]
24. IFN-α production by plasmacytoid dendritic cells stimulated with RNA-containing immune complexes is promoted by NK cells via MIP-1β and LFA-1.
Hagberg N; Berggren O; Leonard D; Weber G; Bryceson YT; Alm GV; Eloranta ML; Rönnblom L
J Immunol; 2011 May; 186(9):5085-94. PubMed ID: 21430220
[TBL] [Abstract][Full Text] [Related]
25. Monocyte-derived dendritic cells from breast cancer patients are biased to induce CD4+CD25+Foxp3+ regulatory T cells.
Ramos RN; Chin LS; Dos Santos AP; Bergami-Santos PC; Laginha F; Barbuto JA
J Leukoc Biol; 2012 Sep; 92(3):673-82. PubMed ID: 22636320
[TBL] [Abstract][Full Text] [Related]
26. Expression of the markers BDCA-2 and BDCA-4 and production of interferon-alpha by plasmacytoid dendritic cells in systemic lupus erythematosus.
Blomberg S; Eloranta ML; Magnusson M; Alm GV; Rönnblom L
Arthritis Rheum; 2003 Sep; 48(9):2524-32. PubMed ID: 13130472
[TBL] [Abstract][Full Text] [Related]
27. Activation of human NK cells by plasmacytoid dendritic cells and its modulation by CD4+ T helper cells and CD4+ CD25hi T regulatory cells.
Romagnani C; Della Chiesa M; Kohler S; Moewes B; Radbruch A; Moretta L; Moretta A; Thiel A
Eur J Immunol; 2005 Aug; 35(8):2452-8. PubMed ID: 15997468
[TBL] [Abstract][Full Text] [Related]
28. Nonplasmacytoid, high IFN-α-producing, bone marrow dendritic cells.
O'Keeffe M; Fancke B; Suter M; Ramm G; Clark J; Wu L; Hochrein H
J Immunol; 2012 Apr; 188(8):3774-83. PubMed ID: 22422879
[TBL] [Abstract][Full Text] [Related]
29. HMGB1 secretion during cervical carcinogenesis promotes the acquisition of a tolerogenic functionality by plasmacytoid dendritic cells.
Demoulin S; Herfs M; Somja J; Roncarati P; Delvenne P; Hubert P
Int J Cancer; 2015 Jul; 137(2):345-58. PubMed ID: 25492101
[TBL] [Abstract][Full Text] [Related]
30. Signalling pathways leading to IFN-alpha production in human plasmacytoid dendritic cell and the possible use of agonists or antagonists of TLR7 and TLR9 in clinical indications.
Guiducci C; Coffman RL; Barrat FJ
J Intern Med; 2009 Jan; 265(1):43-57. PubMed ID: 19093959
[TBL] [Abstract][Full Text] [Related]
31. Characterization of conventional and plasmacytoid dendritic cells in swine secondary lymphoid organs and blood.
Jamin A; Gorin S; Le Potier MF; Kuntz-Simon G
Vet Immunol Immunopathol; 2006 Dec; 114(3-4):224-37. PubMed ID: 16978709
[TBL] [Abstract][Full Text] [Related]
32. Enrichment of CCR6+Foxp3+ regulatory T cells in the tumor mass correlates with impaired CD8+ T cell function and poor prognosis of breast cancer.
Xu L; Xu W; Qiu S; Xiong S
Clin Immunol; 2010 Jun; 135(3):466-75. PubMed ID: 20181533
[TBL] [Abstract][Full Text] [Related]
33. Lactate Induces Pro-tumor Reprogramming in Intratumoral Plasmacytoid Dendritic Cells.
Raychaudhuri D; Bhattacharya R; Sinha BP; Liu CSC; Ghosh AR; Rahaman O; Bandopadhyay P; Sarif J; D'Rozario R; Paul S; Das A; Sarkar DK; Chattopadhyay S; Ganguly D
Front Immunol; 2019; 10():1878. PubMed ID: 31440253
[TBL] [Abstract][Full Text] [Related]
34. Tumor microenvironment converts plasmacytoid dendritic cells into immunosuppressive/tolerogenic cells: insight into the molecular mechanisms.
Demoulin S; Herfs M; Delvenne P; Hubert P
J Leukoc Biol; 2013 Mar; 93(3):343-52. PubMed ID: 23136258
[TBL] [Abstract][Full Text] [Related]
35. Tolerogenic plasmacytoid DC.
Matta BM; Castellaneta A; Thomson AW
Eur J Immunol; 2010 Oct; 40(10):2667-76. PubMed ID: 20821731
[TBL] [Abstract][Full Text] [Related]
36. Genetic engineering of hematopoiesis for targeted IFN-α delivery inhibits breast cancer progression.
Escobar G; Moi D; Ranghetti A; Ozkal-Baydin P; Squadrito ML; Kajaste-Rudnitski A; Bondanza A; Gentner B; De Palma M; Mazzieri R; Naldini L
Sci Transl Med; 2014 Jan; 6(217):217ra3. PubMed ID: 24382895
[TBL] [Abstract][Full Text] [Related]
37. Plasmacytoid Dendritic Cell (pDC) Infiltration Correlate with Tumor Infiltrating Lymphocytes, Cancer Immunity, and Better Survival in Triple Negative Breast Cancer (TNBC) More Strongly than Conventional Dendritic Cell (cDC).
Oshi M; Newman S; Tokumaru Y; Yan L; Matsuyama R; Kalinski P; Endo I; Takabe K
Cancers (Basel); 2020 Nov; 12(11):. PubMed ID: 33198125
[TBL] [Abstract][Full Text] [Related]
38. Research in practice: the impact of interferon-α therapy on immune tolerance.
Raker V; Steinbrink K
J Dtsch Dermatol Ges; 2014 Apr; 12(4):315-9. PubMed ID: 24628847
[TBL] [Abstract][Full Text] [Related]
39. Approaches to the pharmacological modulation of plasmacytoid dendritic cells.
Fabricius D; Jahrsdörfer B
Endocr Metab Immune Disord Drug Targets; 2011 Jun; 11(2):154-64. PubMed ID: 21476966
[TBL] [Abstract][Full Text] [Related]
40. Inhibitory receptors of plasmacytoid dendritic cells as possible targets for checkpoint blockade in cancer.
Tiberio L; Laffranchi M; Zucchi G; Salvi V; Schioppa T; Sozzani S; Del Prete A; Bosisio D
Front Immunol; 2024; 15():1360291. PubMed ID: 38504978
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
